参考文献/References:
1 Munch-Petersen B, Cloos L, Jensen HK, et al. Humanthymidinekinase 1. Regulation in normal and malignant cells. Adv Enzyme Regul, 1995, 35(2):69-89.
2 Boothman DA, Davis TW, Sahijdak WM. Enhanced expressionof thymidine kinase in human cells following ionizingradiation. Int J Radiat Oncol Biol Phys. 1994, 30(2):391-398.
3 Sundseth R, Joyner SS, Moore JT, et al. The anti-human-immunodeficiency virus agent 3’-fluorothymidine induces DNA damage and apoptosis in human lymphoblastoid cells. Antimicrob Agents Chemother, 1996, 40(2):331-335.
4 Rasey JS, Grierson JR, Wiens LW, et al. Validation of FLT uptakeas a measure of thymidine kinase-lactivity in A549 carcinoma cells. J Nucl Med, 2002, 43(9):1210-1217.
5 Vesselle H, Grierson J, Muzi M, et al. In vivo validation of 3’deoxy-3-[18F]fluorothymidine ([18F] FLT)as a proliferation ima-ging tracer inhumans:correlation of [18F]FLT uptake by positron emissiontomography with Ki-67 immunohistochemistry and flow cytometIy in human lung tumors. Clin Cancer Res, 2002, 8(11):3315-3323.
6 Yap CS, Czernin J, Fishbein MC, et al. Evaluation of thoracictumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. Chest, 2006, 129(2):393-401.
7 Cole PD, Smith AK, Kamen BA. Osteosarcoma cells, resistantto methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs. Cancer Chemother Pharmacol, 2002,50(2):111-116.
8 Buck AK, Schirrmeister H, Hetzel M, et al. 3-deoxy-3-[18F] fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. Cancer Res, 2002,62(12):3331-3334.
9 Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation inbrain tumors with ^sup 18F-FLT PET:Comparison with 18F-FDG. J Nucl Med, 2005, 46(6):945-952.
10 Nitzsche EU, Walter M, Schirp U, et al. Combined PET maging of proliferation and glycolysis forfollow up of brachytherapy in brain tumors. In:SNM 50th annual meeting. J Nucl Med, 2003, 44(7):24N-26N.
11 Cerfolio RJ, Ojha B, Bryant AS, et al. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg,2003, 76(3):861-866.
12 Buck AK, Halter G, Schirrmeister H, et al. Imaging proliferation in lung tumors with PET:18F-FLT versus 18F-FDG. J Nucl Med, 2003,44(9):1426-1431.
13 Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with 18F-FLT and positron emission tomography. Nat Med,1998, 4(11):1334-1336.
14 Silverman DH, Pio BS, Satyamurthy N, et al. Monitoring effects of breast cancer chemotherapy with fluorodeoxyglucose and fluoro-Lthymidine. J Nucl Med, 2002, 43(6):308-311.
15 Pio BS, Park CK, Satyamurthy N, et al. Monitoring early and long-term effects of breast cancer chemotherapy with fluorodeoxyglucose and fluoro-L-thymidine. In:ASCO Conference, 2003.
16 Buck AK, Pitterle K, Schirrmeister H, et al.[18F] FLT positron emission tomography forimaging non-Hodgkin’s lymphoma and assessment of proliferative activity. J Nucl Med, 2003, 44(2):188-189.
17 Cobben DC, Elsinga PH, Suurmeijer A J, et al. Detection and grading of soft tissue sarcomas ofthe extremities with 18F-3’-fluoro-3’-deoxy-L-thymidine. Clin Cancer Res, 2004, 10(5):1685-1690.
18 Bastiaannet E, Groen H, Jager PL, et al. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev, 2004, 30(1):83-101.
19 Ham SJ, van der Graaf WT, Pras E, et al. Soft tissue sarcoma of the extremities:A multimodality diagnostic and therapeutic approach. Cancer Treat Rev, 1998, 24(6):373-391.
20 Dittmann H, McBride W, Stout D, et al. Post-irradiation temporal changes in glucose metabolismand cell proliferation in implanted murine tumors as measuredby FDG and FLT PET. J Nucl Med,2002, 43(1):25.
21 Barthel H, Cleij MC, Collingride DR, et al. 18F-3’-Fluoro-3’-Deoxy-LThymldine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with PET. Cancer Res, 2003,63(13):3791-3798.
22 Seitz U, Wagner M, Neumaier B, et al. Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3’[18F]fluoro-3’-deoxythymidine ([18F] FLT) in pancreatic cancer cell lines. Eur J Nucl Med Mol Imaging, 2002, 29(9):1174-1181.
相似文献/References:
[1]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[2]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[3]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[4]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[5]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[6]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[7]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[8]张巧娜,刘汉东.上颌窦上皮-肌上皮癌的CT表现一例[J].国际放射医学核医学杂志,2016,40(3):237.[doi:10.3760/cma.j.issn.1673-4114.2016.03.015]
[9]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[10]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[11]陈立,陈跃.分化型甲状腺癌骨转移诊断及疗效评价的核素显像研究进展[J].国际放射医学核医学杂志,2016,40(6):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
Chen Li,Chen Yue.Diagnosis and evaluation of curative effect progress of radionuclide imaging methods in differentiated thyroid cancer of bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):452.[doi:10.3760/cma.j.issn.1673-4114.2016.06.010]
[12]安淑娴,宋少莉,黄钢.放射性核素标记的凋亡显像剂的研究进展[J].国际放射医学核医学杂志,2015,39(6):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
An Shuxian,Song Shaoli,Huang Gang.Recent advances in apoptosis imaging using radionuclide-labeled tracers[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):470.[doi:10.3760/cma.j.issn.1673-4114.2015.06.008]
[13]陶绪长,罗晓文,关晏星.阿德福韦酯所致低血磷性骨软化症治疗前后SPECT骨显像对比一例[J].国际放射医学核医学杂志,2015,39(6):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):513.[doi:10.3760/cma.j.issn.1673-4114.2015.06.018]
[14]成钊汀,朱小华.99Tcm-MIBI显像在甲状旁腺功能亢进症中的应用及进展[J].国际放射医学核医学杂志,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
Cheng Zhaoting,Zhu Xiaohua.Application and progress of 99Tcm-MIBI scintieraphy in parathyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):37.[doi:10.3760/cma.j.issn.1673-4114.2015.01.009]
[15]林潇,唐明灯.靶向表皮生长因子受体分子探针研究进展[J].国际放射医学核医学杂志,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
Lin Xiao,Tang Mingdeng.Research progresses on molecular probes targeting epidermal growth factor receptor[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):85.[doi:10.3760/cma.j.issn.1673-4114.2015.01.018]
[16]刘晓梅,张芳,黄建敏.肿瘤血管生成的SPECT分子显像研究进展[J].国际放射医学核医学杂志,2015,39(2):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
Liu Xiaomei,Zhang Fang,Huang Jianmin.Research advance on molecular imaging of tumor angiogenesis with SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):170.[doi:10.3760/cma.j.issn.1673-4114.2015.02.015]
[17]刘晋华,张宝牛,赵德善.盆腔融合异位肾一例[J].国际放射医学核医学杂志,2015,39(2):190.[doi:10.3760/cma.j.issn.1673-4114.2015.02.020]
[18]陈明,刘纯,严祥,等.SPECT胃黏膜显像在胃中间横带研究中的价值[J].国际放射医学核医学杂志,2015,39(3):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
Chen Ming,Liu Chun,Yan Xiang,et al.The value of gastric mucosa SPECT in the study of midgastric transverse band[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):197.[doi:10.3760/cma.j.issn.1673-4114.2015.03.002]
[19]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[20]郭宵峰,刘建中,孙琦婷.肺通气/灌注平面显像与肺灌注SPECT/CT对肺栓塞诊断价值的对比性研究[J].国际放射医学核医学杂志,2015,39(4):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]
Guo Xiaofeng,Liu Jianzhong,Sun Qiting.Comparative study of pulmonary ventilation/perfusion planar imaging and pulmonary perfusion SPECT combined with low-dose CT in the diagnosis of pulmonary embolism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(1):277.[doi:10.3760/cma.j.issn.1673-4114.2015.04.001]